For in-store pharmacy chains, the rise of weight-loss drugs represents a business opportunity to reshape shopping habits.
With close to one million downloads, Shotsy is the most popular GLP-1 tracking app on the market, and now meets patients at every stage of their GLP-1 journey.
Novo Nordisk (CPSE:NOVO B) has entered a partnership with Hims & Hers to provide access to its FDA approved GLP-1 obesity and diabetes drugs, Ozempic and Wegovy, through telehealth channels. The ...
Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month for a limited time.
GLP-1 medications mimic a natural hormone that controls appetite, blood sugar, and digestion. Monthly costs range from $199 to over $1,300, depending on the specific medication and insurance coverage.